What is a stock summary page? Click here for an overview.
Business Description
CanSino Biologics Inc
ISIN : CNE100003F01
Share Class Description:
HKSE:06185: Class HCompare
Compare
Traded in other countries / regions
06185.Hong Kong688185.ChinaCJH.GermanyCASBF.USA Index Membership
Hong Kong Stock ConnectiShares MSCI ACWI Ex US Index Fund IPO Date
2019-03-28Description
CanSino Biologics Inc is a China-based company engaged in the research and development, manufacturing, and commercialization of vaccine products for human use. Its products are Menhycia and Menphecia; Convidecia, Convidecia Air, and XBB.1.5 Variant; Ad5-EBOV; PCV13i; PBPV; and DTcP Infant. Its geographic areas are PRC and Overseas. It generates the majority of its revenue from the PRC.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.61 | |||||
| Equity-to-Asset | 0.62 | |||||
| Debt-to-Equity | 0.43 | |||||
| Debt-to-EBITDA | -2.54 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 2.12 | |||||
| Beneish M-Score | -16.89 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 152.5 | |||||
| 3-Year EBITDA Growth Rate | -57.3 | |||||
| 3-Year EPS without NRI Growth Rate | -44.6 | |||||
| 3-Year FCF Growth Rate | -21.2 | |||||
| 3-Year Book Growth Rate | -7.1 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 60.78 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 31.66 | |||||
| 9-Day RSI | 38.81 | |||||
| 14-Day RSI | 44.43 | |||||
| 3-1 Month Momentum % | 37.61 | |||||
| 6-1 Month Momentum % | 86.3 | |||||
| 12-1 Month Momentum % | 163.91 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.38 | |||||
| Quick Ratio | 2.19 | |||||
| Cash Ratio | 1.85 | |||||
| Days Inventory | 263.25 | |||||
| Days Sales Outstanding | 400.94 | |||||
| Days Payable | 77.86 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | 3.19 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 11.65 | |||||
| Operating Margin % | -145.64 | |||||
| Net Margin % | -142.92 | |||||
| FCF Margin % | -108.93 | |||||
| ROE % | -16.02 | |||||
| ROA % | -9.54 | |||||
| ROIC % | -15.92 | |||||
| 3-Year ROIIC % | -38 | |||||
| ROC (Joel Greenblatt) % | -30.2 | |||||
| ROCE % | -12.74 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 2303.33 | |||||
| PS Ratio | 12.93 | |||||
| PB Ratio | 1.57 | |||||
| Price-to-Tangible-Book | 1.62 | |||||
| EV-to-EBIT | -11.1 | |||||
| EV-to-EBITDA | -11.1 | |||||
| EV-to-Revenue | 15.7 | |||||
| EV-to-FCF | -15.22 | |||||
| Price-to-GF-Value | 0.79 | |||||
| Price-to-Net-Current-Asset-Value | 5.42 | |||||
| Price-to-Net-Cash | 17.54 | |||||
| Earnings Yield (Greenblatt) % | -9.01 | |||||
| FCF Yield % | -6.04 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
CanSino Biologics Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 659.614 | ||
| EPS (TTM) (HK$) | -3.819 | ||
| Beta | 1.07 | ||
| 3-Year Sharpe Ratio | -0.27 | ||
| 3-Year Sortino Ratio | -0.42 | ||
| Volatility % | 68.8 | ||
| 14-Day RSI | 44.43 | ||
| 14-Day ATR (HK$) | 1.894364 | ||
| 20-Day SMA (HK$) | 36.2 | ||
| 12-1 Month Momentum % | 163.91 | ||
| 52-Week Range (HK$) | 15.34 - 42.2 | ||
| Shares Outstanding (Mil) | 247.45 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
CanSino Biologics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
CanSino Biologics Inc Stock Events
| Event | Date | Price (HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
CanSino Biologics Inc Frequently Asked Questions
What is CanSino Biologics Inc(HKSE:06185)'s stock price today?
The current price of HKSE:06185 is HK$34.55. The 52 week high of HKSE:06185 is HK$42.20 and 52 week low is HK$15.34.
When is next earnings date of CanSino Biologics Inc(HKSE:06185)?
The next earnings date of CanSino Biologics Inc(HKSE:06185) is 2025-04-30 Est..
Does CanSino Biologics Inc(HKSE:06185) pay dividends? If so, how much?
CanSino Biologics Inc(HKSE:06185) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers